Siriuspoint Ltd Market Cap ($2.68 Billion)
Market Cap & Net Worth: Siriuspoint Ltd (SPNT)
Siriuspoint Ltd market cap. Siriuspoint Ltd (NYSE:SPNT) has a market capitalization of $2.68 Billion ($2.68 Billion) as of November 2, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #5043 globally and #1729 in its home market, demonstrating a -0.31% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Siriuspoint Ltd's stock price $25.88 by its total outstanding shares 116165016 (116.17 Million). Also see SPNT cash flow conversion for how efficiently the company converts equity into cash flow.
Siriuspoint Ltd Market Cap History (2015–2026)
Siriuspoint Ltd market cap history from 2015 to 2026. Data shows growth from $1.48 Billion to $3.01 Billion (6.60% CAGR). Check SPNT share price today for real-time trading data and today's change.
Index Memberships
Siriuspoint Ltd is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P Small-Cap 600 Index
SML
|
$1.56 Trillion | 0.13% | #234 of 602 |
Weight: Siriuspoint Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Siriuspoint Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Siriuspoint Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Siriuspoint Ltd growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.79x
Siriuspoint Ltd's market cap is 0.79 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.53x
Siriuspoint Ltd's market cap is 5.53 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.27 Billion | $708.54 Million | $27.64 Million | 1.80x | 46.10x |
| 2017 | $1.62 Billion | $926.71 Million | $277.80 Million | 1.74x | 5.82x |
| 2018 | $1.06 Billion | $377.51 Million | -$317.69 Million | 2.82x | N/A |
| 2019 | $1.16 Billion | $979.07 Million | $200.62 Million | 1.19x | 5.78x |
| 2020 | $1.05 Billion | $884.57 Million | $143.52 Million | 1.19x | 7.32x |
| 2021 | $944.42 Million | $2.22 Billion | $58.10 Million | 0.42x | 16.26x |
| 2022 | $685.37 Million | $2.17 Billion | -$386.80 Million | 0.32x | N/A |
| 2023 | $1.35 Billion | $2.70 Billion | $354.80 Million | 0.50x | 3.80x |
| 2024 | $1.90 Billion | $2.61 Billion | $199.90 Million | 0.73x | 9.52x |
| 2025 | $2.54 Billion | $3.21 Billion | $459.60 Million | 0.79x | 5.53x |
Competitor Companies of SPNT by Market Capitalization
Companies near Siriuspoint Ltd in the global market cap rankings as of November 2, 2026. Also see SPNT current and non-current assets for a full breakdown of the balance sheet.
Key companies related to Siriuspoint Ltd by market ranking:
- MUENCH.RUECK.UNS.ADR 1/10 (F:MUVB): Ranked #404 globally with a market cap of $70.34 Billion USD ( €60.17 Billion EUR).
- Münchener Rück AG (XETRA:MUV2): Ranked #405 globally with a market cap of $70.09 Billion USD ( €59.95 Billion EUR).
- Swiss Re AG (SW:SREN): Ranked #764 globally with a market cap of $34.98 Billion USD ( CHF27.67 Billion CHF).
- HANN.RUECKV.SE ADR 1/2/ON (F:HNRB): Ranked #862 globally with a market cap of $30.91 Billion USD ( €26.44 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #404 | MUENCH.RUECK.UNS.ADR 1/10 | F:MUVB | $70.34 Billion | €11.00 |
| #405 | Münchener Rück AG | XETRA:MUV2 | $70.09 Billion | €567.00 |
| #764 | Swiss Re AG | SW:SREN | $34.98 Billion | CHF153.35 |
| #862 | HANN.RUECKV.SE ADR 1/2/ON | F:HNRB | $30.91 Billion | €45.40 |
Market Capitalization of Siriuspoint Ltd (2015–2026)
Market capitalization of Siriuspoint Ltd from 2015 to today. Between 2015 and today, Siriuspoint Ltd's market cap moved from $1.48 Billion to $ 3.01 Billion, with a yearly change of 6.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $3.01 Billion | +18.23% |
| 2025 | $2.54 Billion | +33.56% |
| 2024 | $1.90 Billion | +41.29% |
| 2023 | $1.35 Billion | +96.61% |
| 2022 | $685.37 Million | -27.43% |
| 2021 | $944.42 Million | -10.06% |
| 2020 | $1.05 Billion | -9.51% |
| 2019 | $1.16 Billion | +9.13% |
| 2018 | $1.06 Billion | -34.20% |
| 2017 | $1.62 Billion | +26.84% |
| 2016 | $1.27 Billion | -13.87% |
| 2015 | $1.48 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 1st, 2026 the market cap of Siriuspoint Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.68 Billion USD |
| MoneyControl | $2.68 Billion USD |
| MarketWatch | $2.68 Billion USD |
| marketcap.company | $2.68 Billion USD |
| Reuters | $2.68 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Siriuspoint Ltd
SiriusPoint Ltd. provides multi-line reinsurance and insurance products and services worldwide. It operates in four segments: Global P&C Programs, Global Reinsurance, Global Accident & Health, and London Market Specialty. Global P&C Programs segment offers programs space, by further strengthening its offering to clients and distribution partners globally. , Global Reinsurance segment provides cas… Read more